Your browser doesn't support javascript.
loading
Alcohol use in the year following approach bias modification during inpatient withdrawal: secondary outcomes from a double-blind, multi-site randomized controlled trial.
Manning, Victoria; Garfield, Joshua B B; Reynolds, John; Staiger, Petra K; Piercy, Hugh; Bonomo, Yvonne; Lloyd-Jones, Martyn; Jacka, David; Wiers, Reinout W; Verdejo-Garcia, Antonio; Lubman, Dan I.
Afiliación
  • Manning V; Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Australia.
  • Garfield JBB; Turning Point, Eastern Health, Melbourne, Australia.
  • Reynolds J; Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Australia.
  • Staiger PK; Turning Point, Eastern Health, Melbourne, Australia.
  • Piercy H; Alfred Health and Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
  • Bonomo Y; School of Psychology, Deakin University, Geelong, Australia.
  • Lloyd-Jones M; Centre for Drug use, Addictive and Antisocial behaviour Research (CEDAAR), Deakin University, Geelong, Australia.
  • Jacka D; Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Australia.
  • Wiers RW; Turning Point, Eastern Health, Melbourne, Australia.
  • Verdejo-Garcia A; Department of Addiction Medicine, St Vincent's Hospital Melbourne, Melbourne, Australia.
  • Lubman DI; Division of Medicine, Dentistry, and Health Sciences, University of Melbourne, Melbourne, Australia.
Addiction ; 117(11): 2837-2846, 2022 11.
Article en En | MEDLINE | ID: mdl-35792053
ABSTRACT
BACKGROUND AND

AIMS:

Approach bias modification (ApBM) targeting alcohol approach bias has been previously shown to reduce likelihood of relapse during the first 2 weeks following inpatient withdrawal treatment (IWT). We tested whether ApBM's effects endure for a longer period by analysing alcohol use outcomes 3, 6 and 12 months post-discharge.

DESIGN:

A double-blind, sham-controlled randomized controlled trial.

SETTING:

Four IWT units in Melbourne, Australia.

PARTICIPANTS:

Three hundred alcohol IWT patients (173 men, 126 women, 1 non-binary; mean age 43.5 years) were recruited between 4 June 2017 and 14 July 2019. Follow-up data collection was completed on 22 September 2020. INTERVENTION AND CONTROL TRAINING Four ApBM sessions were delivered during IWT. ApBM trained participants (n = 147) to avoid alcohol and approach non-alcohol beverage cues. Controls (n = 153) responded to the same stimuli, but without approach/avoidance training. MEASUREMENTS Date of first lapse was recorded for non-abstinent participants to determine time to first lapse. Time-line follow-back interviews assessed past-month alcohol consumption at each follow-up, with participants reporting no alcohol consumption classified as abstinent. In analyses of past-month abstinence, non-abstinence was assumed in participants lost to follow-up. Number of past-month drinking days, standard drinks and heavy drinking days (five or more standard drinks for women or non-binary; six or more standard drinks for men) were calculated for non-abstinent participants at each follow-up.

FINDINGS:

ApBM significantly delayed time to first lapse [ApBM median 53 days, 95% confidence interval (CI) = 21-61; controls = 12 days, 95% CI = 9-21, P = 0.045]. Past-month abstinence rates at 3-, 6- and 12-month follow-ups were 33/153 (21.6%), 30/153 (19.6%), and 24/153 (15.7%) in controls; and 51/147 (34.7%), 30/147 (20.4%) and 29/147 (19.7%) in the ApBM group, respectively. Past-month abstinence was significantly more likely in ApBM participants than controls at the 3-month follow-up [odds ratio (OR) = 1.93, 95% CI = 1.16-3.23, P = 0.012], but not at 6- or 12-month follow-ups (6-month OR = 1.05, 95% CI = 0.60-1.95, P = 0.862; 12-month OR = 1.32, 95% CI = 0.73-2.40, P = 0.360). No significant group differences were found for indices of alcohol consumption in non-abstinent participants.

CONCLUSIONS:

Approach bias modification for alcohol delivered during inpatient withdrawal treatment helps to prevent relapse, increasing rates of abstinence from alcohol for at least 3 months post-discharge.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Terapia Cognitivo-Conductual / Pacientes Internos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Addiction Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Terapia Cognitivo-Conductual / Pacientes Internos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Addiction Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2022 Tipo del documento: Article País de afiliación: Australia